Published in Genomics and Genetics Weekly, July 21st, 2006
"Ultrasensitive methods to measure very low levels of HCV RNA in biological samples may have diagnostic and prognostic significance and be useful to evaluate the response to antiviral treatment. A sensitive assay to quantify HCV RNA in PBMCs was developed and validated using the iCycler iQ Detection System (Bio-Rad) coupled with TaqMan chemistry," wrote P. Pugnale and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genomics and Genetics Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.